Harrow Health Inc. 11.875... (HROWM)
Harrow Health 11.875% Senior Notes due 2027 Statistics
Share Statistics
Harrow Health 11.875% Senior Notes due 2027 has 41.28M shares outstanding. The number of shares has increased by 163.39% in one year.
| Shares Outstanding | 41.28M |
| Shares Change (YoY) | 163.39% |
| Shares Change (QoQ) | -20.49% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 35.64M |
| Failed to Deliver (FTD) Shares | - |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 0, so undefined% of the outstanding shares have been sold short.
| Short Interest | 0 |
| Short % of Shares Out | undefined% |
| Short % of Float | 0% |
| Short Ratio (days to cover) | 0 |
Valuation Ratios
The PE ratio is undefined and the forward PE ratio is null. Harrow Health 11.875% Senior Notes due 2027's PEG ratio is undefined.
| PE Ratio | undefined |
| Forward PE | n/a |
| PS Ratio | 6.46 |
| Forward PS | null |
| PB Ratio | 11.89 |
| P/FCF Ratio | undefined |
| PEG Ratio | undefined |
Enterprise Valuation
Harrow Health 11.875% Senior Notes due 2027 has an Enterprise Value (EV) of 957.93M.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.82, with a Debt / Equity ratio of undefined.
| Current Ratio | 2.82 |
| Quick Ratio | 2.6 |
| Debt / Equity | undefined |
| Debt / EBITDA | - |
| Debt / FCF | - |
| Interest Coverage | undefined |
Financial Efficiency
Return on Equity is -0.34% and Return on Invested Capital is 0.17%.
| Return on Equity | -0.34% |
| Return on Assets | -0.08% |
| Return on Invested Capital | 0.17% |
| Revenue Per Employee | $599.97K |
| Profits Per Employee | $-112.49K |
| Employee Count | 217 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 3.65 |
Taxes
| Income Tax | 701K |
| Effective Tax Rate | -0.03% |
Stock Price Statistics
The stock price has increased by null% in the last 52 weeks. The beta is 0.17, so Harrow Health 11.875% Senior Notes due 2027's price volatility has been higher than the market average.
| Beta | 0.17 |
| 52-Week Price Change | null% |
| 50-Day Moving Average | 26.34 |
| 200-Day Moving Average | 26.36 |
| Relative Strength Index (RSI) | 48.02 |
| Average Volume (20 Days) | - |
Income Statement
In the last 12 months, Harrow Health 11.875% Senior Notes due 2027 had revenue of 130.19M and earned -24.41M in profits. Earnings per share was -0.75.
| Revenue | 130.19M |
| Gross Profit | 90.55M |
| Operating Income | 431K |
| Net Income | -24.41M |
| EBITDA | 9.72M |
| EBIT | 431K |
| Earnings Per Share (EPS) | -0.75 |
Balance Sheet
The company has 74.08M in cash and 190.5M in debt, giving a net cash position of -116.42M.
| Cash & Cash Equivalents | 74.08M |
| Total Debt | 190.5M |
| Net Cash | -116.42M |
| Retained Earnings | -133.9M |
| Total Assets | 306.63M |
| Working Capital | 85.39M |
Cash Flow
In the last 12 months, operating cash flow was 3.84M and capital expenditures -1.46M, giving a free cash flow of 2.38M.
| Operating Cash Flow | 3.84M |
| Capital Expenditures | -1.46M |
| Free Cash Flow | 2.38M |
| FCF Per Share | 0.07 |
Margins
Gross margin is 69.55%, with operating and profit margins of 0.33% and -18.75%.
| Gross Margin | 69.55% |
| Operating Margin | 0.33% |
| Pretax Margin | -18.21% |
| Profit Margin | -18.75% |
| EBITDA Margin | 7.47% |
| EBIT Margin | 0.33% |
| FCF Margin | 1.83% |
Dividends & Yields
HROWM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for HROWM.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 2.78 |
| Piotroski F-Score | 3 |